347 related articles for article (PubMed ID: 25905427)
21. 3-O-sulfated glucuronide derivative as a potential anti-dengue virus agent.
Hidari KI; Ikeda K; Watanabe I; Abe T; Sando A; Itoh Y; Tokiwa H; Morita K; Suzuki T
Biochem Biophys Res Commun; 2012 Aug; 424(3):573-8. PubMed ID: 22776202
[TBL] [Abstract][Full Text] [Related]
22.
Panchal R; Bapat S; Mukherjee S; Chowdhary A
Indian J Pharmacol; 2021; 53(6):471-479. PubMed ID: 34975135
[TBL] [Abstract][Full Text] [Related]
23. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
[TBL] [Abstract][Full Text] [Related]
24. [Mapping of the B Cell Neutralizing Epitopes on ED III of Envelope Protein from Dengue Virus].
Lin Y; Wen K; Guo Y; Qiu L; Pan Y; Yu L; Di B; Chen Y
Bing Du Xue Bao; 2015 Nov; 31(6):665-73. PubMed ID: 26951013
[TBL] [Abstract][Full Text] [Related]
25. Discovery of novel dengue virus entry inhibitors via a structure-based approach.
Leal ES; Aucar MG; Gebhard LG; Iglesias NG; Pascual MJ; Casal JJ; Gamarnik AV; Cavasotto CN; Bollini M
Bioorg Med Chem Lett; 2017 Aug; 27(16):3851-3855. PubMed ID: 28668194
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a 43 kDa actin protein involved in the DENV-2 binding and infection of ECV304 cells.
Yang J; Zou L; Hu Z; Chen W; Zhang J; Zhu J; Fang X; Yuan W; Hu X; Hu F; Rao X
Microbes Infect; 2013 Apr; 15(4):310-8. PubMed ID: 23376163
[TBL] [Abstract][Full Text] [Related]
27. Peptide inhibitors of dengue virus and West Nile virus infectivity.
Hrobowski YM; Garry RF; Michael SF
Virol J; 2005 Jun; 2():49. PubMed ID: 15927084
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of protein kinase C promotes dengue virus replication.
Noppakunmongkolchai W; Poyomtip T; Jittawuttipoka T; Luplertlop N; Sakuntabhai A; Chimnaronk S; Jirawatnotai S; Tohtong R
Virol J; 2016 Mar; 13():35. PubMed ID: 26931565
[TBL] [Abstract][Full Text] [Related]
29. Superficial vimentin mediates DENV-2 infection of vascular endothelial cells.
Yang J; Zou L; Yang Y; Yuan J; Hu Z; Liu H; Peng H; Shang W; Zhang X; Zhu J; Rao X
Sci Rep; 2016 Dec; 6():38372. PubMed ID: 27910934
[TBL] [Abstract][Full Text] [Related]
30. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
[TBL] [Abstract][Full Text] [Related]
31. Early dengue virus interactions: the role of dendritic cells during infection.
Santos Souza HF; da Silva Almeida B; Boscardin SB
Virus Res; 2016 Sep; 223():88-98. PubMed ID: 27381061
[TBL] [Abstract][Full Text] [Related]
32. Strategies for development of Dengue virus inhibitors.
Noble CG; Chen YL; Dong H; Gu F; Lim SP; Schul W; Wang QY; Shi PY
Antiviral Res; 2010 Mar; 85(3):450-62. PubMed ID: 20060421
[TBL] [Abstract][Full Text] [Related]
33. A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection.
Fraser JE; Watanabe S; Wang C; Chan WK; Maher B; Lopez-Denman A; Hick C; Wagstaff KM; Mackenzie JM; Sexton PM; Vasudevan SG; Jans DA
J Infect Dis; 2014 Dec; 210(11):1780-91. PubMed ID: 24903662
[TBL] [Abstract][Full Text] [Related]
34. The Phosphatidylserine and Phosphatidylethanolamine Receptor CD300a Binds Dengue Virus and Enhances Infection.
Carnec X; Meertens L; Dejarnac O; Perera-Lecoin M; Hafirassou ML; Kitaura J; Ramdasi R; Schwartz O; Amara A
J Virol; 2016 Jan; 90(1):92-102. PubMed ID: 26468529
[TBL] [Abstract][Full Text] [Related]
35. Peptide inhibitor of Japanese encephalitis virus infection targeting envelope protein domain III.
Zu X; Liu Y; Wang S; Jin R; Zhou Z; Liu H; Gong R; Xiao G; Wang W
Antiviral Res; 2014 Apr; 104():7-14. PubMed ID: 24468276
[TBL] [Abstract][Full Text] [Related]
36. A Global Interactome Map of the Dengue Virus NS1 Identifies Virus Restriction and Dependency Host Factors.
Hafirassou ML; Meertens L; Umaña-Diaz C; Labeau A; Dejarnac O; Bonnet-Madin L; Kümmerer BM; Delaugerre C; Roingeard P; Vidalain PO; Amara A
Cell Rep; 2017 Dec; 21(13):3900-3913. PubMed ID: 29281836
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional insights of STAT2-NS5 interaction for the identification of NS5 antagonist - An approach for restoring interferon signaling.
Choubey SK; Nachiappan M; Richard M; Chitra JP; Jeyakanthan J
Comput Biol Chem; 2020 Oct; 88():107332. PubMed ID: 32721859
[TBL] [Abstract][Full Text] [Related]
38. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
39. Dengue Virus Evolution under a Host-Targeted Antiviral.
Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
[TBL] [Abstract][Full Text] [Related]
40. Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens.
Marceau CD; Puschnik AS; Majzoub K; Ooi YS; Brewer SM; Fuchs G; Swaminathan K; Mata MA; Elias JE; Sarnow P; Carette JE
Nature; 2016 Jul; 535(7610):159-63. PubMed ID: 27383987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
